openPR Logo
Press release

Gene Therapy Market: Demand Forecast and Future Outlook (2034)

07-28-2025 06:26 AM CET | Health & Medicine

Press release from: Expert Market Research

Gene Therapy Market: Demand Forecast and Future Outlook (2034)

Gene Therapy Market Overview

The gene therapy market has emerged as one of the most innovative segments within the global healthcare industry, offering ground-breaking treatment options for genetic disorders by targeting the root cause at the DNA level. Unlike traditional therapies that manage symptoms, gene therapy aims for a more permanent solution, correcting defective genes or introducing new ones to fight diseases. This transformative approach is revolutionizing treatment protocols for various complex conditions including cancers, rare diseases, and neurological disorders. Supported by advancing technologies, strong research pipelines, and a favorable regulatory environment, gene therapy is gaining robust traction among biotech companies, research institutions, and investors worldwide.

Get a free sample report: https://bit.ly/46vPSYK

Gene Therapy Market Insights with Expert Market Research

Shaping the future of advanced therapies, the gene therapy market stands as a testament to how modern science is transforming healthcare. Expert Market Research plays a crucial role by providing detailed insights, robust market forecasts, and in-depth competitor analyses, empowering stakeholders with actionable intelligence. As more patients benefit from these innovative treatments, industry players are accelerating research to unlock the full potential of gene therapy. With continuous advancements, collaborative partnerships, and expert-backed strategies, the market is poised for unprecedented growth, offering renewed hope for millions battling genetic and chronic conditions worldwide.

Gene Therapy Market Size

The gene therapy market reached a significant value of USD 7.81 Billion in 2024, underlining its growing acceptance in mainstream healthcare. With approvals for novel therapies and an expanding patient pool benefiting from these cutting-edge treatments, the market's value is only expected to surge in the coming decade. High-value collaborations between pharma giants and biotech innovators are adding to this upward trajectory. Furthermore, rising awareness and better reimbursement frameworks are boosting adoption. The market's impressive size indicates strong momentum, paving the way for emerging players and established pharma companies to capitalize on untapped opportunities in advanced therapy medicinal products (ATMPs).

Gene Therapy Market Trends

The gene therapy market is witnessing transformative trends reshaping the future of healthcare. A major trend includes the development of precision and personalized gene therapies tailored for individual genetic profiles, enhancing treatment efficacy. The rising number of FDA approvals and breakthrough designations for gene therapies is a testament to rapid R&D advancements. Strategic partnerships, mergers, and acquisitions are fostering innovation while expanding global reach. Moreover, the adoption of viral vectors, especially adeno-associated viral vectors, is accelerating due to their high transduction efficiency. Another notable trend is the exploration of gene-editing tools like CRISPR, which are revolutionizing pipeline development and opening new avenues for the treatment of rare and previously untreatable diseases.

Read full report with table of content: https://bit.ly/44OKIWz

Gene Therapy Market Opportunities and Challenges

The gene therapy market presents vast opportunities, especially with rising investments from public and private sectors, government support, and technological breakthroughs. Emerging markets in Asia Pacific and Latin America hold immense potential due to improving healthcare infrastructure and rising awareness about genetic disorders. However, the market is not without its challenges. High treatment costs and complex manufacturing processes hinder widespread accessibility. Additionally, ethical concerns and stringent regulatory approvals can delay product launches. Despite these barriers, continuous advancements in vector design, delivery systems, and collaborative research are addressing challenges, making gene therapy a promising solution for conditions that currently lack effective treatments.

Gene Therapy Market Segmentation

Based on Indication

Neurological Disorder
Oncological Disorders
Rare Diseases
Eye Disorders
Others

By Vector

Non-Viral Vector
Oligonucleotides
Others
Viral Vector
Retroviral Vectors
Adeno-associated Viral Vectors
Others

Regional Markets

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Gene Therapy Market Growth

The gene therapy market is anticipated to experience remarkable growth driven by breakthrough advancements, robust pipelines, and significant investments. The sector is expected to grow at a striking CAGR of 22.80% during the forecast period of 2025-2034. Growing incidences of genetic disorders, an aging population, and the unmet need for effective treatments are propelling demand. Biopharmaceutical companies are heavily investing in next-generation gene-editing tools, innovative vectors, and scalable manufacturing solutions. The expanding adoption of digital tools and AI to enhance research outcomes is also fueling progress. As regulatory pathways become clearer and more supportive, more innovative therapies will enter the market, accelerating growth and transforming patient care.

Gene Therapy Market Forecast

The future outlook for the gene therapy market is exceedingly promising, with the market projected to reach an impressive USD 60.90 Billion by 2034. This exponential rise stems from robust pipelines, landmark approvals, and ongoing research investments. As more therapies gain market authorization, treatment options for various rare and life-threatening diseases will expand, driving higher adoption rates globally. Governments and health organizations are also prioritizing the inclusion of gene therapy within national health policies to ensure better patient access. Additionally, collaborations between academia and industry will fast-track breakthroughs, pushing the boundaries of what gene therapy can achieve in modern medicine over the next decade.

Gene Therapy Market Competitor Analysis

The competitive landscape of the gene therapy market is shaped by leading pharmaceutical giants and biotech innovators striving for breakthroughs in advanced therapies. Key players include:

AstraZeneca: Focuses on pioneering gene therapy solutions through advanced research collaborations.

Boehringer Ingelheim International GmbH: Innovates in rare disease gene therapies and personalized medicine.

GlaxoSmithKline plc: Expands its portfolio with cutting-edge gene therapy trials and commercial products.

Novartis AG: A global leader known for its successful commercial gene therapies for rare conditions.

CHIESI Farmaceutici SpA: Invests in respiratory and rare disease gene therapies worldwide.

Sunovion Pharmaceuticals Inc: Advances gene therapy programs for neurological conditions.

Teva Pharmaceutical Industries Ltd: Develops affordable gene therapy solutions targeting multiple indications.

Mylan N.V.: Strengthens its gene therapy pipeline through strategic partnerships and R&D.

Orion Corporation: Works on innovative gene therapies for neurodegenerative diseases.

Merck & Co., Inc.: Invests in advanced gene editing and vector technologies.

Grifols, S.A.: Develops gene therapy platforms for hematological disorders.

Abbott: Focuses on diagnostic tools to complement gene therapy applications.

F. Hoffmann-La Roche Ltd: Leads research in oncology-focused gene therapy solutions.

Vectura Group plc: Develops targeted gene delivery systems for respiratory diseases.

Pfizer Inc: Holds a strong pipeline of promising gene therapies for various conditions.

Alkermes: Explores gene therapies for complex mental health conditions.

Almirall, S.A.: Focuses on dermatology-related gene therapy advancements.

Genentech, Inc: A Roche subsidiary, pioneering gene therapies for oncology and rare diseases.

Biogen: Leads the industry with its neurodegenerative disease-focused gene therapy programs.

Astellas Pharma Inc.: Develops cutting-edge genetic medicine and regenerative therapies.

Find More Report:

Epigenomics Market: https://bit.ly/45fzoCX

Cryotherapy Market: https://bit.ly/4lFHr1C

Clinical IT Market: https://bit.ly/44ILPam

Precision Medicine Market: https://bit.ly/4f1WNLl

Epigenetics Market: https://bit.ly/3GWY8Xm

Media Contact:

Company Name: Claight Corporation
Contact Person: Deepanshu Choudhary, Digital Marketing
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com

About Us:

Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others. Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gene Therapy Market: Demand Forecast and Future Outlook (2034) here

News-ID: 4121648 • Views:

More Releases from Expert Market Research

Bed and Bath Linen Market Trends, Growth & Forecast 2025-2034
Bed and Bath Linen Market Trends, Growth & Forecast 2025-2034
The global bed and bath linen market is witnessing strong growth due to increasing consumer focus on home décor, comfort, and luxury. Rising disposable incomes, urbanization, and the booming hospitality sector are further boosting demand for premium-quality bed sheets, pillowcases, towels, and bathrobes. Technological innovations in fabrics, such as antimicrobial, wrinkle-resistant, and sustainable textiles, are shaping consumer preferences. In addition, the expansion of online distribution channels has made luxury and
Global Fruit Juice Market Size, Report and Forecast 2025-2034
Global Fruit Juice Market Size, Report and Forecast 2025-2034
The latest report from Expert Market Research titled, "Global Fruit Juice Market Size, Report and Forecast 2025-2034," offers a comprehensive analysis of the global fruit juice market, examining it across various segments such as types, flavours, distribution channels, and key regions. The report identifies and tracks the latest trends shaping the industry and evaluates their impact on the overall market dynamics. It also provides a thorough assessment of the market, covering
Global Fluorspar Market Forecast 2025-2034: Growth, Trends, and Key Insights
Global Fluorspar Market Forecast 2025-2034: Growth, Trends, and Key Insights
According to the latest report by Expert Market Research (EMR), the global Fluorspar Market Size is projected to grow at a CAGR of 5.60% between 2025 and 2034. The market is expected to experience significant growth by 2034, driven by the increasing demand for fluorspar across industries such as manufacturing, chemicals, and metallurgy. Fluorspar, also known as fluorite, is a key industrial mineral composed of calcium fluoride (CaF2). It is crucial
Why will smart pulse oximeters market hit $3.50Bn by 2034?
Why will smart pulse oximeters market hit $3.50Bn by 2034?
smart pulse oximeters market Overview The smart pulse oximeters market has become a pivotal part of modern healthcare infrastructure, especially in the wake of increasing cardiovascular and respiratory ailments. These technologically enhanced devices measure blood oxygen saturation and pulse rate, often offering wireless connectivity to mobile apps for better health tracking. Their growing application in hospitals, ambulatory settings, and home healthcare environments reflects the market's evolving dynamics. Key drivers include the

All 5 Releases


More Releases for Gene

DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034" The DNA and Gene Cloning Services Market Size is valued
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period? The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks. The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies. In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal